| Structure | Chemical Name | CAS | MF |
|
1H-Indol-7-amine, 4-bromo-2,3-dihydro-, hydrochloride (1:2)
|
2306268-58-4
|
C8H9BrN2.2ClH
|
|
6-(2,3-dihydro-1,4-benzodioxin-5-yl)-N-[3-[(dimethylamino)methyl]phenyl]-2-methoxy-pyridin-3-amine
|
2306268-61-9
|
C23H25N3O3
|
|
7-methyl-7-azaspiro[3.5]nonan-2-one
|
2306268-80-2
|
C9H15NO
|
|
1,7-Naphthyridine-7(6H)-carboxylic acid, 3-bromo-2-chloro-5,8-dihydro-, 1,1-dimethylethyl ester
|
2306268-82-4
|
C13H16BrClN2O2
|
|
4-chloro-3,3-dimethyl-2,3-dihydro-1H-pyrrolo[3,2-c]pyridine
|
2306269-27-0
|
C9H11ClN2
|
|
4-Azaspiro[2.5]octane-4-carboxylic acid, 7-hydroxy-, 1,1-dimethylethyl ester
|
2306269-68-9
|
C12H21NO3
|
|
6-Azaspiro[3.5]nonan-2-ol, hydrochloride (1:1)
|
2306270-07-3
|
C8H15NO.ClH
|
|
1-(tert-butoxycarbonylamino)-3-(trifluoromethyl)cyclobutanecarboxylic acid
|
2306270-08-4
|
C11H16F3NO4
|
|
3-chloroimidazo[1,2-a]pyridine-6-sulfonyl chloride
|
2306270-26-6
|
C7H4Cl2N2O2S
|
|
2-Oxa-8-azaspiro[4.5]decan-4-one, hydrochloride (1:1)
|
2306270-36-8
|
C8H14ClNO2
|
|
4-methylindolin-7-amine dihydrochloride
|
2306270-42-6
|
|
|
Spiro[3H-indole-3,4′-piperidin]-2(1H)-one, 5-methyl-, hydrochloride (1:1)
|
2306270-99-3
|
C13H16N2O.ClH
|
|
4-(2,2-dimethoxyethyl)bicyclo[2.2.1]heptane-1-carboxylic acid
|
2306271-02-1
|
C12H20O4
|
|
5-Oxa-2-azaspiro[3.4]octan-7-one, hydrochloride (1:1)
|
2306271-65-6
|
C6H10ClNO2
|
|
tert-butyl 3-amino-6,8-dihydro-5H-1,7-naphthyridine-7-carboxylate
|
2306271-77-0
|
C13H19N3O2
|
|
3-ethoxybicyclo[1.1.1]pentan-1-amine hydrochloride
|
2306272-15-9
|
|
|
2-oxa-6-azaspiro[3.3]heptane-1-carboxylic acid
|
2306272-34-2
|
C6H9NO3
|
|
6-Thia-2-azaspiro[3.5]nonane, 6,6-dioxide, hydrochloride (1:1)
|
2306272-52-4
|
C7H13NO2S.ClH
|
|
2-(4-((Benzyloxy)carbonyl)piperazin-1-yl)acetic acid hydrochloride
|
2306272-72-8
|
C14H19ClN2O4
|
|
5-methoxy-2-azaspiro[3.3]heptane hydrochloride
|
2306272-79-5
|
C7H14ClNO
|
|
tert-butyl N-(6-bromopyrazolo[1,5-a]pyridin-3-yl)carbamate
|
2306273-07-2
|
C12H14BrN3O2
|
|
7-Azaspiro[3.5]nonane-2-methanol, hydrochloride (1:1)
|
2306273-13-0
|
C9H17NO.ClH
|
|
4-fluoroindolin-7-amine dihydrochloride
|
2306274-49-5
|
|
|
3,8-Diazabicyclo[3.2.1]octane-8-carboxylic acid, 6-oxo-3-(phenylmethyl)-, 1,1-dimethylethyl ester
|
2306274-51-9
|
C18H24N2O3
|
|
tert-butyl 2-(p-tolylsulfonyloxymethyl)-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-5-carboxylate
|
2306274-60-0
|
C19H25N3O5S
|
|
2-(6-bromo-8-fluoro-3-quinolyl)acetonitrile
|
2306274-61-1
|
C11H6BrFN2
|
|
methyl 3-(4-fluorophenyl)azetidine-3-carboxylate hydrochloride
|
2306274-73-5
|
C11H13ClFNO2
|
|
2-Azaspiro[3.5]nonan-7-ol, hydrochloride (1:1)
|
2306275-14-7
|
C8H16ClNO
|
|
3-Oxetanamine, 3-(fluoromethyl)-N-methyl-
|
2306275-73-8
|
C5H10FNO
|
|
2-Azaspiro[3.5]nonane-2-carboxylic acid, 6-oxo-, 1,1-dimethylethyl ester
|
2306275-77-2
|
C13H21NO3
|
|
5,5-Difluorotetrahydro-2H-pyran-3-amine hydrochloride
|
2306275-99-8
|
C5H10ClF2NO
|
|
8-bromo-3-fluoro-imidazo[1,2-a]pyridine-2-carboxylic acid
|
2306276-04-8
|
C8H4BrFN2O2
|
|
2,2-difluorospiro[2.3]hexan-5-ol
|
2306276-11-7
|
C6H8F2O
|
|
2-methyl-2-azaspiro[3.3]heptan-6-amine dihydrochloride
|
2306276-66-2
|
C7H15ClN2
|
|
2,5-Dioxaspiro[3.4]octane-7-methanol
|
2306276-69-5
|
C7H12O3
|
|
methyl 2-(6-bromo-8-fluoro-3-quinolyl)acetate
|
2306276-87-7
|
C12H9BrFNO2
|
|
6-chloro-7-fluoro-quinoxaline-2-carboxylic acid
|
2306277-07-4
|
C9H4ClFN2O2
|
|
2-(6-bromo-8-fluoro-3-quinolyl)ethanol
|
2306277-14-3
|
C11H9BrFNO
|
|
4-Azaspiro[2.5]octan-7-one, hydrochloride (1:1)
|
2306277-85-8
|
C7H12ClNO
|
|
tert-butyl 2-(chloromethyl)-6,7-dihydro-4H-thiazolo[4,5-c]pyridine-5-carboxylate
|
2306277-89-2
|
C12H17ClN2O2S
|
|
tert-butyl N-[(1-aminocyclohexyl)methyl]carbamate hydrochloride
|
2306278-10-2
|
C12H25ClN2O2
|
|
methyl 6-bromo-8-fluoro-quinoline-3-carboxylate
|
2306278-42-0
|
C11H7BrFNO2
|
|
5-fluoro-7-nitro-indoline
|
2306278-45-3
|
C8H7FN2O2
|
|
Oxetane, 3-(bromomethyl)-3-methoxy-
|
2306278-53-3
|
C5H9BrO2
|
|
2,3-Dihydro-1H-pyrrolo[2,3-c]pyridin-5(6H)-one
|
2306369-98-0
|
C7H8N2O
|
|
PROTAC ERRα ligand 2
|
2306388-57-6
|
C20H13F6NO4
|
|
PROTAC ERRα Degrader-1
|
2306388-84-9
|
C54H49Cl2F6N7O8
|
|
PROTAC ERRα Degrader-2
|
2306388-85-0
|
C57H55Cl2F6N7O8
|
|
(S,R,S)-AHPC-C6-NH2
|
2306389-03-5
|
C29H43N5O4S
|
|
1-Piperazineacetic acid, 4-[[(4R,5S)-4,5-bis(4-chlorophenyl)-4,5-dihydro-2-[4-methoxy-2-(1-methylethoxy)phenyl]-1H-imidazol-1-yl]carbonyl]-2-oxo-
|
2306390-08-7
|
C32H32Cl2N4O6
|
|
(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}(methyl)amino)-3-(6-methylpyridin-3-yl)propanoic acid
|
2306433-40-7
|
C25H24N2O4
|
|
L-Phenylalanine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-N,β-dimethyl-, (βR)-
|
2306437-90-9
|
C26H25NO4
|
|
1-(4-heptylphenyl)-3-nitropropan-1-one
|
2306446-28-4
|
C16H23NO3
|
|
Guanosine, 8-methyl-2'-O-methyl-
|
2306782-64-7
|
C12H17N5O5
|
|
Abiraterone-beta-D-Glucuronide
|
2307194-33-6
|
C30H39NO7
|
|
Abiraterone Impurity 18
|
2307194-36-9
|
C30H38NO7+
|
|
Abiraterone Impurity 19
|
2307194-37-0
|
C30H40NO7+
|
|
Triphenylene, 2-(2-chlorophenyl)-
|
2307216-62-0
|
C24H15Cl
|
|
2,3,8,9,14,15-hexa(4-formylphenyl)diquinoxalino[2,3-a:2’,3’-c]phenazine
|
2307218-00-2
|
C66H36N6O6
|
|
BAY-885
|
2307249-33-6
|
C25H28F3N7O2
|
|
[Ir (dFOMeppy)2(5, 5 DCF)3Bpy)] PF6
|
2307271-69-6
|
C36H22F16IrN4O2P
|
|
EST73502
|
2307458-82-6
|
C19H27ClF2N2O2
|
|
FAK ligand-Linker Conjugate 1
|
2307461-45-4
|
C25H28F3N5O6S
|
|
Benzonitrile, 4-[3-[2-(4-hydroxy-1-piperidinyl)acetyl]-2,5-dimethyl-1H-pyrrol-1-yl]-
|
2307472-03-1
|
C20H23N3O2
|
|
1H-Isoindole-1,3(2H)-dione, 5-[(2-aminoethyl)amino]-2-(2,6-dioxo-3-piperidinyl)-
|
2307476-92-0
|
C15H16N4O4
|
|
5-[(5-aminobutyl)amino]-2-(2,6-dioxo-3-piperidinyl)-1H-Isoindole-1,3(2H)-dione,
|
2307476-95-3
|
C18H22N4O4
|
|
Thalidomide-O-C5-NH2
|
2307477-23-0
|
C18H21N3O5
|
|
(5S,5'S)-5,5'-(azanediylbis(methylene))bis(3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one)
|
2307625-63-2
|
C28H33F2N5O6
|
|
4,6-Quinazolinediamine, N4-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]-
|
2307628-67-5
|
C21 H17 N7 O
|
|
Benzenamine, 3-bromo-4,5-dichloro-N,N-diphenyl-
|
2307629-51-0
|
C18H12BrCl2N
|
|
2-(1-AMINOETHYL)BENZONITRILE HYDROCHLORIDE
|
2307734-64-9
|
C9H11ClN2
|
|
8-Benzyl 3-ethyl 2-oxo-8-azabicyclo[3.2.1]octane-3,8-dicarboxylate
|
2307736-42-9
|
C18H21NO5
|
|
(R)-2-(3,5-difluorophenyl)piperidine hydrochloride
|
2307737-00-2
|
C11H14ClF2N
|
|
7-BROMOCHROMAN-4-AMINE HYDROCHLORIDE
|
2307737-83-1
|
C9H11BrClNO
|
|
(E)-3-(5-chloro-2,4-difluorophenyl)acrylic acid
|
2307843-32-7
|
C9H5ClF2O2
|
|
E3 ligase Ligand-Linker Conjugates 15
|
2308035-51-8
|
C19H19N3O8
|
|
FGFR1/DDR2 inhibitor 1
|
2308497-58-5
|
C28H22F3N5O
|
|
Carbamic acid, N-[[4-(4-methyl-5-thiazolyl)phenyl]methyl]-, 1,1-dimethylethyl ester
|
2308507-34-6
|
C16H20N2O2S
|
|
tert-Butyl N-[6-chloro-2-(methylamino)-3-nitro-4-pyridyl]carbamate
|
2308524-71-0
|
C11H15ClN4O4
|
|
3,3''-bis(trifluoromethyl)-[1,1':4',1''-terphenyl]-4,4''-
|
2308530-30-3
|
C22H12F6O4
|
|
8-Azabicyclo[3.2.1]oct-2-ene-2,8-dicarboxylic acid, 8-(1,1-dimethylethyl) ester
|
2309122-41-4
|
C13H19NO4
|
|
ABO (hydrochloride)
|
2309172-24-3
|
C9H14Cl2N2O2
|
|
LDN-192960 (hydrochloride)
|
2309172-48-1
|
C18H21ClN2O2S
|
|
1-NBD-decanoyl-2-decanoyl-sn-Glycerol
|
2309189-98-6
|
C29H46N4O8
|
|
Citrulline-specific Probe-rhodamine
|
2309313-01-5
|
C39H37N7O8
|
|
1-Propanol, 3-amino-2-fluoro-, hydrochloride (1:1), (2S)-
|
2309433-02-9
|
C3H9ClFNO
|
|
Bicyclo[1.1.1]?pentane-?1-?carboxylic acid, 2,?2-?difluoro-?3-?phenyl-
|
2309454-98-4
|
C12H10F2O2
|
|
Benzoic acid, 4-chloro-2-[(2-furanylmethyl)amino]-5-sulfo-
|
2309462-39-1
|
C12H10ClNO6S
|
|
3-Azetidinecarboxylic acid, 1-(fluorosulfonyl)-
|
2309463-31-6
|
C4H6FNO4S
|
|
(1-Methylaminomethyl-cyclopropyl)-methanol hydrochloride
|
2309475-53-2
|
C6H14ClNO
|
|
Mavorixafor trihydrochloride
|
2309699-17-8
|
C21H28ClN5
|
|
N-[(1S)-4-[(2-chloro-1-iminoethyl)amino]-1-[[(phenylmethyl)amino]carbonyl]butyl]-6-(dimethylamino)-2-naphthalenecarboxamide,monohydrochloride
|
2309756-20-3
|
C27H33Cl2N5O2
|
|
AZ7550 hydrochloride
|
2309762-40-9
|
C??H??ClN?O?
|
|
ONO-AE3-208 (sodium salt)
|
2309931-05-1
|
C24H20FN2NaO3
|
|
LYN-1604 dihydrochloride
|
2310109-38-5
|
C33H44Cl3N3O2
|
|
LDN193189 Tetrahydrochloride
|
2310134-98-4
|
C25H23ClN6
|
|
N-deacetylated BMS-202
|
2310135-18-1
|
C23H27N3O2
|
|
LMPTP INHIBITOR 1 dihydrochloride
|
2310135-46-5
|
C28H37ClN4O
|
|
PDK4-IN-1 hydrochloride
|
2310262-11-2
|
C22H20ClN3O2
|
|
Avanafil Impurity 50
|
2310299-29-5
|
C14H14ClN3O5S
|